Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Arcellx Inc (ACLX)
NASDAQ:ACLX
Arcellx Inc (ACLX) Stock Price & Analysis
120 Followers
ACLX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$30.88 - $75.10
Previous Close$62.1
Volume202.06K
Average Volume (3M)472.64K
Market Cap
$3.32B
Enterprise Value$2.84B
Total Cash (Recent Filing)$573.92M
Total Debt (Recent Filing)$87.36M
Price to Earnings (P/E)―
Beta0.77
Next Earnings
Aug 12, 2024EPS Estimate
-$0.52Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.06
Shares Outstanding53,502,572
10 Day Avg. Volume488,875
30 Day Avg. Volume472,641
Standard Deviation0.23
R-Squared0.00296
Alpha0.06
Financial Highlights & Ratios
Price to Book (P/B)6.19
Price to Sales (P/S)76.49
Price to Cash Flow (P/CF)12.90
P/FCF Ratio13.90
Enterprise Value/Market CapN/A
Enterprise Value/Revenue21.54
Enterprise Value/Gross Profit25.71
Enterprise Value/Ebitda-57.88
Forecast
1Y Price Target
$80.00Price Target Upside27.59% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering13
Arcellx Inc News
Bulls Say, Bears Say
Bulls Say
Manufacturing AdvantageArcellx/Gilead is expected to have a faster and more consistent manufacturing process compared to Legend/JnJ, which is a major long-term commercial advantage.
Market OpportunityThe BCMA CAR-T market is substantial with an estimated $12 billion in peak RRMM sales.
Product EfficacyArcellx enrolled much sicker patients in Phase 1 compared to Legend/JnJ's CARTITUDE-1 but still showed similar efficacy.
Bears Say
Clinical TrialsSupply constraints leading to clinical trial delays or a delayed platform may fail to produce additional assets.
EfficacyAnito-cel may fail to match Carvykti’s efficacy profile or an unexpected safety event(s) occurs.
ManufacturingContinuing difficulty in CART manufacturing highlights Arcellx / Kite advantage.
---
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
ACLX FAQ
What was Arcellx Inc’s price range in the past 12 months?
Arcellx Inc lowest stock price was $30.88 and its highest was $75.10 in the past 12 months.
What is Arcellx Inc’s market cap?
Currently, no data Available
When is Arcellx Inc’s upcoming earnings report date?
Arcellx Inc’s upcoming earnings report date is Aug 12, 2024 which is in 17 days.
How were Arcellx Inc’s earnings last quarter?
Arcellx Inc released its earnings results on May 09, 2024. The company reported -$0.14 earnings per share for the quarter, beating the consensus estimate of -$0.508 by $0.368.
Is Arcellx Inc overvalued?
According to Wall Street analysts Arcellx Inc’s price is currently Undervalued.
Does Arcellx Inc pay dividends?
Arcellx Inc does not currently pay dividends.
What is Arcellx Inc’s EPS estimate?
Arcellx Inc’s EPS estimate is -$0.52.
How many shares outstanding does Arcellx Inc have?
Arcellx Inc has 53,502,570 shares outstanding.
What happened to Arcellx Inc’s price movement after its last earnings report?
Arcellx Inc reported an EPS of -$0.14 in its last earnings report, beating expectations of -$0.508. Following the earnings report the stock price went down -5.67%.
Which hedge fund is a major shareholder of Arcellx Inc?
Among the largest hedge funds holding Arcellx Inc’s share is Perceptive Advisors LLC. It holds Arcellx Inc’s shares valued at 274M.
---
Arcellx Inc Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$80.00 (27.59% Upside)
$80.00 (27.59% Upside)
Blogger Sentiment
Bullish
ACLX Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 531.8K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▲ 0.5%
Last 30 Days ▼ 1.5%
Last 30 Days ▼ 1.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
82.80%
12-Months-Change
Fundamentals
Return on Equity
-12.63%
Trailing 12-Months
Asset Growth
25.16%
Trailing 12-Months
Company Description
Arcellx Inc
Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases.
---
ACLX Stock 12 Month Forecast
Average Price Target
$80.00
▲(27.59% Upside)
Technical Analysis
Adverum Biotechnologies
―
Allogene Therapeutics
―
Arvinas Holding Company
―
Bluebird Bio
―
Best Analysts Covering ACLX
1 Year
1 Year Success Rate
12/13 ratings generated profit
1 Year Average Return
+92.93%
reiterated a buy rating 5 months ago
Copying Daina Graybosch's trades and holding each position for 1 Year would result in 92.31% of your transactions generating a profit, with an average return of +92.93% per trade.
---